Publication: Efficacy of calcitriol to bone resorption and PTH level: Clinical study
| dc.contributor.author | Narong Bunyaratavej | en_US |
| dc.contributor.author | Nipat Kitimanon | en_US |
| dc.contributor.author | Khaevimol Tunjariyanond | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-09-07T09:44:07Z | |
| dc.date.available | 2018-09-07T09:44:07Z | |
| dc.date.issued | 2001-12-01 | en_US |
| dc.description.abstract | Study of the effect of calcitriol (Rocaltrol®) to bone markers and PTH level in 146 menopausal women. The result showed a dose of calcitriol 0.75 microgram/day for one month significantly decreased the level of PTH, bone marker for resorption and NMID osteocalcin 61.55, 69.92, 60.02 percent respectively (p=0.000). The other group which took calcitriol 0.5 microgram/day had little change to such markers. The active form of vitamin D benefits bone health by enhancing osteocalcin formation, in addition vitamin D has moderate antiresorption and suppression of PTH secretion. | en_US |
| dc.identifier.citation | Journal of the Medical Association of Thailand. Vol.84, No.SUPPL. 2 (2001) | en_US |
| dc.identifier.issn | 01252208 | en_US |
| dc.identifier.other | 2-s2.0-0035735832 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/26638 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035735832&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Efficacy of calcitriol to bone resorption and PTH level: Clinical study | en_US |
| dc.type | Conference Paper | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035735832&origin=inward | en_US |